Drug therapy in autism: a present and future perspective

Area of Science:

• Neurodevelopmental Disorders
• Autism Spectrum Disorder (ASD) Etiology
• Autism Treatment Modalities

Background:

• Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by communication and social skill deficits, alongside restricted behaviors.
• Traditionally viewed as a static condition, research increasingly points to a multifactorial etiology involving immune, neuroinflammatory, and genetic factors.
• Associated conditions include fragile X syndrome, tuberous sclerosis, epilepsy, and Down syndrome.

Purpose of the Study:

• To review the multifactorial etiology of Autism Spectrum Disorder (ASD).
• To explore current and emerging therapeutic interventions for ASD.
• To highlight the need for novel pharmacological approaches to reduce ASD prevalence.

Main Methods:

• Literature review of autism's etiopathogenesis.
• Analysis of current non-pharmacological and pharmacological treatment strategies.
• Examination of the efficacy of various drug classes in managing ASD behavioral symptoms.

Main Results:

• ASD etiology involves impaired immune responses, neuroinflammation, oxidative stress, and genetic factors.
• Current treatments include educational therapies (speech, sensory integration) and pharmacological agents (SSRIs, antidepressants, anticonvulsants, antipsychotics).
• These interventions show effectiveness in managing behavioral symptoms, though a cure remains elusive.

Conclusions:

• Effective management of Autism Spectrum Disorder (ASD) symptoms is achievable through a combination of therapies.
• Further research into novel drug classes with new mechanisms of action is crucial.
• Developing innovative treatments may lead to a future reduction in ASD prevalence.